Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Interest Coverage Ratio: 2015-2020

Historic Interest Coverage Ratio for Outlook Therapeutics (OTLK) over the last 6 years, with Sep 2020 value amounting to -526.18.

  • Outlook Therapeutics' Interest Coverage Ratio fell 771.37% to -526.18 in Q3 2020 from the same period last year, while for Sep 2020 it was -20.97, marking a year-over-year decrease of 100.31%. This contributed to the annual value of -22.71 for FY2024, which is 8.22% down from last year.
  • As of Q3 2020, Outlook Therapeutics' Interest Coverage Ratio stood at -526.18, which was down 1,865.00% from -26.78 recorded in Q2 2020.
  • Outlook Therapeutics' 5-year Interest Coverage Ratio high stood at -1.36 for Q3 2017, and its period low was -526.18 during Q3 2020.
  • Its 3-year average for Interest Coverage Ratio is -62.13, with a median of -9.72 in 2020.
  • Per our database at Business Quant, Outlook Therapeutics' Interest Coverage Ratio surged by 94.29% in 2017 and then plummeted by 771.37% in 2020.
  • Outlook Therapeutics' Interest Coverage Ratio (Quarterly) stood at -36.38 in 2016, then spiked by 87.82% to -4.43 in 2017, then slumped by 106.61% to -9.15 in 2018, then slumped by 49.63% to -13.69 in 2019, then slumped by 771.37% to -526.18 in 2020.
  • Its Interest Coverage Ratio stands at -526.18 for Q3 2020, versus -26.78 for Q2 2020 and -9.72 for Q1 2020.